— Andrew Simmons, PhD, Senior Scientist, Preclinical Research, Takeda Pharmaceutical Company
NDRI — National Disease Research Interchange — has been at the forefront of fulfilling the biomedical research community’s human tissue needs since 1980. We work with both academic and corporate investigators worldwide to provide high-quality human biospecimens to advance biomedical research.
NDRI serves as a Human Tissue and Organ for Research Resource (HTORR). We receive funding and oversight from federal agencies, including the Office of the Director at the National Institutes of Health (NIH), to support the recovery and distribution of donated human organs and tissues for use in research programs across multiple disciplines.
Every prospective researcher completes an application process to determine whether the project falls within NDRI’s capabilities and mission. We tailor sample acquisition and processing to meet the specific needs of approved projects. NDRI can provide an array of tissue types from both diseased and non-diseased surgical, autopsy, and low post-mortem interval (PMI) donors. Preservation methods include fresh, frozen, and fixed suitable for various analytical techniques.
To learn more, contact:
Email or call (800) 222- NDRI (6374), ext. 391